Reconalla, Marites A.
HRN: 21-64-02 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2022
CEFTRIAXONE 1G (VIAL)
07/20/2022
07/27/2022
IV
1g
Q12
AP
Waiting Final Action
07/20/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/20/2022
07/27/2022
IV
500mg
Q8H
AP
Waiting Final Action